Overview

Detailed Summary

SMS Lifesciences India Limited is primarily involved in the manufacturing and export of Active Pharmaceutical Ingredients (APIs) and their intermediates. The company operates multiple facilities across Hyderabad.
Originally incorporated as a real estate private limited company in 2006, SMS Lifesciences has undergone several transformations, including demergers and acquisitions.
The company holds significant recognition as an export house since 1997, indicating expertise in global pharmaceutical supply chains.
With three multi-product facilities and a research center, SMS Lifesciences engages in contract manufacturing and research assignments for an international clientele.
A strategic demerger in 2017 positioned the company to leverage semi-regulated units, enhancing its manufacturing capabilities and international market reach.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 490 Cr
Volatility: Low Risk
P/E Ratio: 24.7
Industry P/E: 35.0
PEG Ratio: 0.1
P/B Ratio: 2.5
52W High: 1,778.35
52W Low: 1,050.05

Sales CAGR

1Y: 12.67%
3Y: -0.96%
5Y: 5.44%
10Y: —

Profit CAGR

1Y: 195.89%
3Y: -5.57%
5Y: 18.50%
10Y: —

ROE

TTM: 9.06%
3Y: 8.87%
5Y: 10.58%
10Y: 10.92%

ROCE

TTM: 12.31%
3Y: 13.04%
5Y: 14.43%
10Y: 15.01%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
KILITCH		134.70	609 Cr	20.17	2.18	0.00	10.79	12.00	6.44
ZIMLAB		72.32	540 Cr	77.22	1.88	0.00	2.62	6.18	1.50
AMANTA		130.60	518 Cr	33.81	2.46	0.00	7.41	11.89	3.14
HALEOSLABS		1600.00	514 Cr	25.89	2.49	0.09	9.06	12.31	5.32
JENBURPH		1162.95	512 Cr	14.75	2.60	1.78	17.63	23.20	15.37
ALBERTDAVD		787.00	417 Cr	-279.71	1.06	0.68	-0.38	0.75	-0.29
VALIANTLAB		76.31	408 Cr	-124.24	1.31	0.00	-1.05	0.74	-0.71
Median: 7 Co.	—	134.70	514 Cr	20.17	2.18	0.00	7.41	11.89	3.14

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	69	72	90	93	78	85	89	83	81	95
Expenses	61	63	79	76	70	72	82	71	68	81
Operating Profit	7.92	9.29	11	16	8.56	13	7.42	12	14	14
OPM %	11.44	12.89	12.62	17.60	10.91	15.08	8.33	14.19	16.69	14.82
Other Income	0.27	0.58	2.36	0.44	2.04	0.06	2.34	1.00	0.42	0.18
Interest	2.81	2.34	2.84	2.40	2.14	2.14	2.03	1.87	1.62	1.54
Depreciation	3.73	3.73	3.78	3.68	3.76	3.76	3.80	3.82	3.89	3.91
Profit Before Tax	1.66	3.81	7.10	11	4.70	6.92	3.93	7.02	8.49	8.78
Tax %	126.51	-8.14	8.87	33.27	29.79	29.77	11.45	37.61	24.38	24.26
Net Profit	-0.44	4.12	6.47	7.10	3.30	4.85	3.48	4.38	6.43	6.65
EPS in Rs	2.20	14.24	19.53	23.15	15.46	18.08	9.83	13.75	20.19	21.89

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	416	291	295	389	358	339	386	335
Expenses	343	235	235	316	287	275	300	294
Operating Profit	73	55	60	73	71	64	86	40
OPM %	17.60	18.98	20.24	18.81	19.92	18.93	22.35	12.09
Other Income	2.55	2.28	1.78	14	5.42	3.83	4.86	5.44
Interest	5.51	5.14	4.53	6.17	6.79	10	8.71	8.18
Depreciation	6.38	7.86	7.86	10	11	15	15	15
Profit Before Tax	25	15	20	33	17	9.85	26	23
Tax %	29.69	30.58	30.72	22.70	31.43	35.74	28.47	29.07
Net Profit	18	10	14	25	11	6.33	19	16
EPS in Rs	—	31.87	44.81	79.61	30.51	30.03	66.52	65.66
Dividend Payout %	2.54	0.00	3.35	1.79	3.96	4.99	2.26	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.02	3.02	3.02	3.02	3.02	3.02	3.02
Reserves	103	113	126	149	166	174	194
Borrowings	40	59	65	80	100	101	86
Other Liabilities	124	78	108	125	126	113	107
Total Liabilities	270	253	302	357	395	391	390
Fixed Assets	118	124	130	142	228	223	232
CWIP	3.29	16	38	51	0.85	6.00	0.40
Investments	0.95	0.04	0.04	0.04	0.04	0.04	0.04
Other Assets	148	113	134	163	166	161	158
Total Assets	270	253	302	357	395	391	390

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	30	15	35	-11	15	24	34
Cash from Investing Activity	-44	-27	-26	-7.14	-31	-18	-15
Cash from Financing Activity	15	12	-2.55	11	17	-6.56	-19
Net Cash Flow	1.35	-0.03	6.39	-7.55	0.29	-0.71	-0.07

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	70.32%	70.32%	70.68%	71.19%	71.41%	71.41%	71.41%	71.41%	71.41%	71.41%	71.80%	72.11%
FIIs	0.00%	0.00%	0.00%	0.00%	0.01%	0.02%	0.00%	0.00%	0.03%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.29%	0.30%
Public	29.68%	29.68%	29.32%	28.81%	28.58%	28.57%	28.59%	28.59%	28.56%	28.57%	27.91%	27.60%
Total Shareholders	8,475	8,443	8,233	8,116	7,861	7,849	7,626	7,479	7,412	7,521	7,125	6,937

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY25

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.